EPILIGHT HAIR REMOVAL SYSTEM

K963249 · Esc Medical Systems , Ltd. · GEX · Jul 7, 1997 · General, Plastic Surgery

Device Facts

Record IDK963249
Device NameEPILIGHT HAIR REMOVAL SYSTEM
ApplicantEsc Medical Systems , Ltd.
Product CodeGEX · General, Plastic Surgery
Decision DateJul 7, 1997
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 878.4810
Device ClassClass 2
AttributesTherapeutic

Intended Use

The EpiLight™ Hair Removal System is intended for long term removal of unwanted hair.

Device Story

EpiLight™ Hair Removal System is an electro-optic medical device for photothermal treatment of unwanted hair. Device uses light energy to target hair follicles; principle of operation involves thermal destruction of hair follicles while minimizing adverse effects on surrounding tissue. System specifications compared against predicate laser systems to ensure equivalent performance. Device is intended for professional use. Clinical evidence includes multi-center studies evaluating hair clearance rates and adverse event profiles compared to predicate devices. Benefits include long-term hair removal.

Clinical Evidence

Multi-center clinical study conducted on human subjects to evaluate hair clearance rates and adverse effects. Results compared to published data for predicate devices. Analysis indicates the device is as safe and effective as predicates for long-term hair removal. Theoretical study also performed to model temperature distribution in hair follicles during treatment.

Technological Characteristics

Electro-optic medical device; non-laser light source. Conforms to IEC601.1-1 (Medical Electrical Equipment, General Requirements for Safety). Complies with 21 CFR 1040.1 FDA laser performance standards where applicable. System utilizes light energy for photothermal effect.

Indications for Use

Indicated for the removal of unwanted hair in patients seeking long-term hair removal.

Regulatory Classification

Identification

(1) A carbon dioxide laser for use in general surgery and in dermatology is a laser device intended to cut, destroy, or remove tissue by light energy emitted by carbon dioxide.(2) An argon laser for use in dermatology is a laser device intended to destroy or coagulate tissue by light energy emitted by argon.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0} K 963249 # 1. 510(K) SUMMARY- SUMMARY OF SAFETY AND EFFECTIVENESS Submitter's name: ESC Medical Systems, Ltd JUL - 7 1997 Submitter's address: Yokneam Industrial Park PO Box 240 Yokneam 20692 ISRAEL Telephone: 011-972-4-959-9000 Fax: 001-972-4-959-9050 Name of device: EpiLight™ Hair Removal System ## Predicate devices: 1. LT-100 ND:YAG Laser Hair Removal System made by Thermolase Corporation of San Diego, California. 510K #K950019. 2. Epilator 629 made by American Hair Removal System of Southern Pines, North Carolina. 510K #K892514. ## Description of device: EpiLight™ Hair Removal System is an electro optic medical device designed for effective photothermal treatment of unwanted hair and its long-term removal ## Summary: Pursuant to section 513(I) of the Safe Medical Devices Act of 1990, ESC Medical Systems has elected to include in this premarket notification a Summary of Safety and Effectiveness upon which we believe a substantial equivalence determination for the EpiLight™ Hair Removal System can be based. It is our understanding that there are presently no FDA regulations describing the form and content of such Summaries. With this in mind, ESC Medical Systems has tried to anticipate what information may be of particular interest to the agency regarding safety and effectiveness of the PhotoDerm® PL. ## Intended use: The EpiLight™ Hair Removal System is intended for long term removal of unwanted hair. The LT-100 ND:YAG Laser Hair Removal System made by Thermolase Corporation of San Diego, California. 510K #K950019 was classified as a class II medical device by the General and Plastic Surgery Devices Panel. The AHRS Epilator 629 was classified as class III medical device by General and Plastic Surgery Devices Panel. ESC Medical Systems’ EpiLight™ Hair Removal System is substantially equivalent to these devices. ESC Proprietary Information I.1-1 {1} Comparing technical characteristics: Both a technical comparison and clinical trials were performed by ESC Medical Systems to establish his equivalence: ESC has performed a detailed comparison of the technical specifications of predicate device #1 and the EpiLight™ Hair Removal System. The results have documented that the system specifications of EpiLight™ are well within the range of the technical specifications of predicate device #1. A theoretical study was conducted to establish the temperature distribution resulting from a treatment of a hair follicle by the EpiLight™ Hair Removal System. The temperatures reached as a result of exposure to the light energy of system, was evaluated. It is the view of ESC Medical Systems that this analysis demonstrates that the EpiLight™ Hair Removal System is an effective way of long term removal of unwanted hair, and is safe in minimizing the adverse effects in the surrounding tissues. Performance: In addition, ESC Medical Systems has also conducted a multi-center clinical study in which unwanted hair was treated by the EpiLight™ Hair Removal System. This study was analyzed and the clearance rates and rate of occurrence of adverse effects of the EpiLight™ Hair Removal System were established. This data was compared to published data on the clearance rate and adverse effects of predicate devices. It is ESC’s opinion that this comparison demonstrates that the EpiLight™ Hair Removal System is as safe and as effective as the predicate devices in the long term removal of unwanted hair. No performance standards applicable to the EpiLight™ Hair Removal System have been adopted under Section 514 of the Act. However, 1. The EpiLight™ Hair Removal System is an electro medical device and conforms with the voluntary international standard IEC601.1-1, Medical Electrical Equipment, Part 1: General Requirements for Safety. 2. Although the EpiLight™ Hair Removal System is not a laser device, substantial equivalence to a laser device is being claimed. As such ESC has made efforts to comply, where applicable, with 21 CFR 1040.1 FDA laser performance standard. In summary we believe that the analysis, the clinical data and the standards which the EpiLight™ Hair Removal System meets make it substantially equivalent to the predicate devices. ESC Proprietary Information I.1-2 {2} DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 Dr. Zvi Ladin Vice President ESC Medical Systems Yokneam Industrial Park PO Box 240 Yokneam 20692, Israel JUL - 7 1997 Re: K963249 Trade Name: EpiLigh™ Hair Removal System Regulatory Class: II Product Code: GEX Dated: June 9, 1997 Received: June 10, 1997 Dear Dr. Ladin: We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the {3} Page 2 - Dr. Zvi Ladin Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations. This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for *in vitro* diagnostic devices), please contact the Office of Compliance at (301) 594-4595. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html". Sincerely yours, ![img-0.jpeg](img-0.jpeg) Celia M. Witten, Ph.D., M.D. Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4} Page ___ of ___ 510(k) Number (if known): K963249 Device Name: EpiLigh™ Hair Removal System Indications For Use: The EpiLight™ Hair Removal System is used for the removal of unwanted hair (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) ![img-1.jpeg](img-1.jpeg) Prescription Use ☑ (Per 21 CFR 801.109) OR Over-The-Counter Use ☐ (Optional Format 1-2-96)
Innolitics

Panel 1

/
Sort by
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...